BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2318854)

  • 1. A point mutation at the putative ATP-binding site of protein kinase C alpha abolishes the kinase activity and renders it down-regulation-insensitive. A molecular link between autophosphorylation and down-regulation.
    Ohno S; Konno Y; Akita Y; Yano A; Suzuki K
    J Biol Chem; 1990 Apr; 265(11):6296-300. PubMed ID: 2318854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of site-specific mutants altered at protein kinase C beta 1 isozyme autophosphorylation sites.
    Zhang J; Wang L; Petrin J; Bishop WR; Bond RW
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6130-4. PubMed ID: 8327493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phorbol esters on protein kinase C-zeta.
    Ways DK; Cook PP; Webster C; Parker PJ
    J Biol Chem; 1992 Mar; 267(7):4799-805. PubMed ID: 1537859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells.
    Goodall AR; Turner NA; Walker JH; Ball SG; Vaughan PF
    J Neurochem; 1997 Jan; 68(1):392-401. PubMed ID: 8978751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters.
    Wang XJ; Warren BS; Rupp T; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1994 Dec; 15(12):2795-803. PubMed ID: 8001237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic analysis of the regulatory and catalytic domains of protein kinase C.
    Kaibuchi K; Fukumoto Y; Oku N; Takai Y; Arai K; Muramatsu M
    J Biol Chem; 1989 Aug; 264(23):13489-96. PubMed ID: 2760032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.
    Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC
    Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of epidermal protein kinase C in mice sensitive or resistant to phorbol ester.
    Hirabayashi N; Warren BS; Wang XJ; Petersen-Marht S; Beltran L; Davis MM; Ashendel CL; DiGiovanni J
    Mol Carcinog; 1990; 3(3):171-80. PubMed ID: 2372371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular distribution of protein kinase C alpha and betaI in bovine spermatozoa, and their regulation by calcium and phorbol esters.
    Lax Y; Rubinstein S; Breitbart H
    Biol Reprod; 1997 Feb; 56(2):454-9. PubMed ID: 9116146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity.
    Li W; Yu JC; Shin DY; Pierce JH
    J Biol Chem; 1995 Apr; 270(14):8311-8. PubMed ID: 7713939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of novel protein kinases C delta and C epsilon upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts.
    Ohno S; Mizuno K; Adachi Y; Hata A; Akita Y; Akimoto K; Osada S; Hirai S; Suzuki K
    J Biol Chem; 1994 Jul; 269(26):17495-501. PubMed ID: 8021256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of protein kinase C-gamma is independent of a functional kinase domain.
    Freisewinkel I; Riethmacher D; Stabel S
    FEBS Lett; 1991 Mar; 280(2):262-6. PubMed ID: 1901548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that protein kinase C alpha has reduced affinity towards 1,2-dioctanoyl-sn-glycerol: the effects of lipid activators on phorbol ester binding and kinase activity.
    MacEwan DJ; Mitchell R; Johnson MS; Thomson FJ; Lutz EM; Clegg RA; Connor K
    Eur J Pharmacol; 1993 Jun; 246(1):9-18. PubMed ID: 8354345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of protein kinase C in the transcriptional regulation of 12-O-tetradecanoylphorbol-13-acetate-inducible genes modulated by AP-1 or non-AP-1 transacting factors.
    Tseng CP; Kim YJ; Kumar R; Verma AK
    Carcinogenesis; 1994 Apr; 15(4):707-11. PubMed ID: 8149484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.
    Brooks G; Wilson RE; Dooley TP; Goss MW; Hart IR
    Cancer Res; 1991 Jun; 51(12):3281-8. PubMed ID: 2040003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells.
    Akimoto K; Mizuno K; Osada S; Hirai S; Tanuma S; Suzuki K; Ohno S
    J Biol Chem; 1994 Apr; 269(17):12677-83. PubMed ID: 7513693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential down-regulation of protein kinase C subspecies in normal human melanocytes: possible involvement of the zeta subspecies in growth regulation.
    Oka M; Ogita K; Ando H; Kikkawa U; Ichihashi M
    J Invest Dermatol; 1995 Oct; 105(4):567-71. PubMed ID: 7561160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tannic acid on 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C activation in NIH 3T3 cells.
    Kuo ML; Wu WS; Lee KC; Lin JK
    Biochem Pharmacol; 1993 Oct; 46(8):1327-32. PubMed ID: 8240380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C; Gescher A; Bradshaw TD; Pettit GR
    Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.